WHO urges rich countries to donate shots instead of vaccinating children

GENEVA (Reuters) – The World Health Organization urged rich countries on Friday to reconsider plans to vaccinate children and instead donate COVID-19 shots to the COVAX scheme for poorer countries.

WHO chief Tedros Adhanom Ghebreyesus also said the second year of the pandemic was set to be more deadly than the first, with India a huge concern.

“I understand why some countries want to vaccinate their children and adolescents, but right now I urge them to reconsider and to instead donate vaccines to #COVAX,” he told a virtual meeting in Geneva.

Indian Prime Minister Narendra Modi sounded the alarm over the rapid spread of the coronavirus through India’s vast countryside on Friday, as the country’s official tally of infections crossed 24 million and over 4,000 people died for the third straight day.

More than 160.71 million people have been reported to be infected by the coronavirus globally and 3,477,379​ have died, according to a Reuters tally.

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

(Reporting by Emma Farge in Geneva and Michael Shields and John Miller in Zurich; Writing by Nick Macfie; Editing by Catherine Evans)

WHO chief laments ‘shocking imbalance’ in COVID-19 shot distribution

GENEVA (Reuters) -There is a “shocking imbalance” in the distribution of COVID-19 vaccines worldwide and most countries do not have anywhere near enough shots to cover health workers and others at high-risk, WHO Director-General Tedros Adhanom Ghebreyesus said on Friday.

More than 700 million jabs have been administered worldwide against the disease, but 87% have gone to high income or upper middle-income countries, with low income countries receiving just 0.2%, he said.

“On average in high-income countries, almost one in four people has received a COVID-19 vaccine. In low-income countries, it’s one in more than 500,” Tedros told a briefing.

The COVAX facility has delivered nearly 38.4 million doses of COVID-19 vaccines to 102 countries across six continents, six weeks after it began to roll out supplies, the GAVI vaccine alliance and WHO said on Thursday. It aims to deliver more than 2 billion doses this year but has faced delays.

“We hope to be able to catch up during April and May. The problem is not getting vaccines out of COVAX, the problem is getting them in,” Tedros said, decrying the scarcity of supply.

The AstraZeneca shot – the mainstay of the COVAX program so far – has been hit by safety concerns after reports of blood clots in some recipients.

Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries of the shot amid concern about a possible very small risk of rare blood clots.

GAVI CEO Seth Berkley, asked whether COVAX was negotiating for more doses of the vaccine being shunned by some countries, said that the Anglo-Swedish company’s supply chain had “picked up”.

He hoped that the supply of AstraZeneca vaccine made by the Serum Institute of India – whose doses are now being kept domestically for use against an accelerating epidemic – would improve over time.

“As countries decide they are going to prioritize one vaccine or another that may free up doses, and in doing we will try to make sure those doses are made available without delay, if countries are willing to make that happen,” Berkely said.

(Reporting by Stephanie Nebehay and John Revill Writing by Andrew HeavensEditing by Andrew Cawthorne and Peter Graff)